Log in
NYSE:MKD

Molecular Data Stock Forecast, Price & News

$1.15
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.07
Now: $1.15
$1.15
50-Day Range
$1.09
MA: $1.20
$1.56
52-Week Range
$0.57
Now: $1.15
$11.90
Volume190,459 shs
Average Volume84,034 shs
Market Capitalization$132.30 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites that are intended to solve pain points for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. The company was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone86 21 5436 5166
Employees482

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$132.30 million
Next Earnings DateN/A
OptionableNot Optionable
$1.15
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MKD News and Ratings via Email

Sign-up to receive the latest news and ratings for MKD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Molecular Data (NYSE:MKD) Frequently Asked Questions

How has Molecular Data's stock price been impacted by COVID-19 (Coronavirus)?

Molecular Data's stock was trading at $1.89 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MKD stock has decreased by 39.2% and is now trading at $1.15.
View which stocks have been most impacted by COVID-19
.

Who are some of Molecular Data's key competitors?

What other stocks do shareholders of Molecular Data own?

Who are Molecular Data's key executives?

Molecular Data's management team includes the following people:
  • Dr. Dongliang Chang, Founder & Chairman of Board of Directors (Age 44)
  • Dr. Zheng Wang, CEO & Director (Age 51)
  • Mr. Zhaohong Li, Chief Financial Officer (Age 51)
  • Mr. Qiaoqiao Sun, Co-Chief Financial Officer (Age 40)
  • Mr. Jingming Zhong, Compliance Officer

When did Molecular Data IPO?

(MKD) raised $69 million in an initial public offering on the week of December 30th 2019. The company issued 11,500,000 shares at a price of $5.00-$7.00 per share. AMTD, Fosun Hani and Boustead Securities acted as the underwriters for the IPO and Tiger Brokers and Guotai Junan International were co-managers.

What is Molecular Data's stock symbol?

Molecular Data trades on the New York Stock Exchange (NYSE) under the ticker symbol "MKD."

How do I buy shares of Molecular Data?

Shares of MKD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Molecular Data's stock price today?

One share of MKD stock can currently be purchased for approximately $1.15.

How big of a company is Molecular Data?

Molecular Data has a market capitalization of $132.30 million. Molecular Data employs 482 workers across the globe.

What is Molecular Data's official website?

The official website for Molecular Data is www.molbase.cn.

How can I contact Molecular Data?

The company can be reached via phone at 86 21 5436 5166.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.